Methods of treating muscular wasting diseases using NF-kappaB activation inhibitors

摘要

Methods for treating muscular wasting diseases such as Duchenne muscular dystrophy are disclosed. Specifically, the methods include administering to a subject in need of treatment for a muscular wasting disease, an NF-kappaB activation inhibitor capable of blocking the activation of NF-kappaB.